Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 36
1946 168
1947 224
1948 435
1949 254
1950 51
1951 338
1952 657
1953 683
1954 711
1955 697
1956 1065
1957 1200
1958 1121
1959 1262
1960 1309
1961 1339
1962 1005
1963 1259
1964 2602
1965 3421
1966 3966
1967 4140
1968 4278
1969 4361
1970 4492
1971 4672
1972 4697
1973 4526
1974 4692
1975 5298
1976 5478
1977 6032
1978 6549
1979 6532
1980 6617
1981 6958
1982 7328
1983 7750
1984 8636
1985 9222
1986 9546
1987 10496
1988 11246
1989 12330
1990 12535
1991 12109
1992 12614
1993 13354
1994 14225
1995 14484
1996 15547
1997 15491
1998 16254
1999 17064
2000 18211
2001 19136
2002 20654
2003 22805
2004 24181
2005 27396
2006 29115
2007 31274
2008 33488
2009 35945
2010 39853
2011 42875
2012 46515
2013 48615
2014 51631
2015 53487
2016 52216
2017 51728
2018 51053
2019 26319
2020 774
Text availability
Article attribute
Article type
Publication date

Search Results

971,131 results
Results by year
Filters applied: . Clear all
Page 1
Tumors of the hand
Mavrogenis AF, et al. Eur J Orthop Surg Traumatol 2017 - Review. PMID 28585186
Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy.
Wargo JA, et al. Semin Oncol 2015 - Review. PMID 26320064 Free PMC article.
There have been significant advances in cancer treatment over the past several years through the use of chemotherapy, radiation therapy, molecularly targeted therapy, and immunotherapy. ...Thus, the influence of chemotherapy, radiation therapy, and molecularly targeted therapy on the host anti-tumor immune response and the host anti-host response (ie, autoimmune toxicity) must be taken into consideration when designing immunotherapy-based combination regimens. ...
There have been significant advances in cancer treatment over the past several years through the use of chemotherapy, radiation therapy
Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
Lohmueller J and Finn OJ. Pharmacol Ther 2017 - Review. PMID 28322974 Free PMC article.
Successes of immune checkpoint inhibitors (ICIs) and chimeric antigen receptor (CAR) T cell therapy in curing patients with otherwise lethal cancers have validated immunotherapy as a treatment for cancer and have inspired excitement for its broader potential. ...In this review we examine three major cancer immunotherapy modalities: immunomodulatory antibodies, CAR T cell therapy and vaccines. ...
Successes of immune checkpoint inhibitors (ICIs) and chimeric antigen receptor (CAR) T cell therapy in curing patients with otherwise …
Editorial
Harris CC. Carcinogenesis 2017. PMID 28064179
Correspondence
Gupta A, et al. J Natl Compr Canc Netw 2016. PMID 27799517
Multidisciplinary sarcoma care
Pollock RE, et al. Curr Probl Surg 2018. PMID 30526918
Sarcoma
Skubitz KM and D'Adamo DR. Mayo Clin Proc 2007 - Review. PMID 17976362
Sarcomas comprise a heterogeneous group of mesenchymal neoplasms. They can be grouped into 2 general categories, soft tissue sarcoma and primary bone sarcoma, which have different staging and treatment approaches. ...
Sarcomas comprise a heterogeneous group of mesenchymal neoplasms. They can be grouped into 2 general categories, soft tissue sarcoma …
California dreaming
Khuri FR. Cancer 2017. PMID 28976539 Free article.
971,131 results
Jump to page
Feedback